Could organ-on-a-chip technology help identify drug failures before clinical trials? Jim Corbett of Emulate discusses the ...

Two cancer drugs appeared almost identical in conventional screening, but a new 3D Cell Painting method exposed striking ...

Researchers have found that the TRPV1 pain receptor responds differently to individual stimuli, revealing functional ...

MSA and Parkinson's share the same protein pathology, yet MSA progresses far faster. Could earlier detection reveal why and ...

Two experimental compounds derived from a phase II metabolite have demonstrated improved anti-inflammatory activity in ...

A gene responsible for producing a critical enzyme in inflammatory signalling has been identified after more than 30 years, ...

The right signals can make or break an organoid model. From growth and differentiation to downstream drug testing, cytokines and growth factors are critical to creating cultures researchers can rely ...

A hybrid microrobotic platform combining living bacteria, nanoparticles and targeted chemotherapy has achieved 82.4 percent ...

From self-driving laboratories to advanced cellular models, ELRIG Drug Discovery 2026 showcases technologies helping researchers generate better data, evaluate drug candidates and improve early ...

Researchers at Nagoya University have identified BCAT1, an enzyme involved in proline supply for collagen synthesis, as a ...

Cambridge biotech bit.bio has released ioAstrocytes 2.0, a genetically matched human astrocyte model designed to support ...

Poor recovery, inconsistent growth and changes in morphology can affect organoid research. How much experimental variability ...